1921
Volume 78, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Fascioliasis is highly endemic in the Andean region of South America. Newer serological assays have improved our ability to diagnose acute fascioliasis. The diagnosis was established by serology (Fas2-ELISA or Western blot) in 10 patients. Identifiable exposure included ingestion of watercress ( = 8), alfalfa juice ( = 5), and lettuce ( = 1). Computed tomography of the abdomen showed hepatomegaly ( = 9), track-like hypodense lesions with subcapsular location ( = 8), and subcapsular hematoma ( = 2). Radiologic sequelae included cyst calcifications detectable at least 3 years after treatment. Stool examinations were negative for eggs; serology was positive (Arc II [ = 2], Fas2-ELISA [ = 6], Western blot [ = 2]). The syndrome of eosinophilia, fever, and right upper quadrant pain, elevated transaminases without jaundice, hypodense liver lesions on CT, and an appropriate exposure history suggests acute fascioliasis. Fascioliasis is specifically treatable with a single dose of triclabendazole.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2008.78.222
2008-02-01
2017-11-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/78/2/0780222.html?itemId=/content/journals/10.4269/ajtmh.2008.78.222&mimeType=html&fmt=ahah

References

  1. Esteban JG, Bargues MD, Mas-Coma S, 1998. Geographical distribution, diagnosis and treatment of human fascioliasis: a review. Res Rev Parasitol 58 : 13–42.
  2. Mas-Coma S, Bargues MD, Esteban JG, 1999. Human fasciolosis. Dalton JP, ed. Fasciolosis. New York: CAB International Publishing, 411–434.
  3. Mas-Coma S, 2005. Epidemiology of fascioliasis in human endemic areas. J Helminthol 79 : 207–216.
  4. Mas-Coma MS, Esteban JG, Bargues MD, 1999. Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ 77 : 340–346.
  5. Marcos L, Maco V, Florencio L, Terashima A, Samalvides F, Espinoza JR, Miranda E, Tantaleán M, Gotuzzo E, 2005. Altas tasas de prevalencia de fasciolosis humana en el Peru: una enfermedad emergente. Rev Peru Enf Infec Trop 3 : 8–13.
  6. Esteban JG, Gonzalez C, Bargues MD, Angles R, Sánchez C, Náquira C, Mas-Coma S, 2002. High fascioliasis infection in children linked to a man-made irrigation zone in Peru. Trop Med Int Health 7 : 339–348.
  7. Knobloch J, Delgado E, Alvarez A, Reymann U, Bialek R, 1985. Human fascioliasis in Cajamarca/Peru. I. Diagnostic methods and treatment with praziquantel. Trop Med Parasitol 36 : 88–90.
  8. Marcos L, Maco V, Terashima A, Samalvides F, Espinoza JR, Gotuzzo E, 2004. Hiperendemicidad de fasciolosis humana en el Valle del Mantaro: factores de riesgo de la infección por Fasciola hepatica. Rev Gastroenterol Peru 24 : 158–164.
  9. Blancas G, Terashima A, Maguina C, Vera L, Alvarez H, Tello R, 2004. Fasciolosis humana y compromiso gastrointestinal: estudio de 277 pacientes en el Hospital Nacional Cayetano Heredia, 1970–2002. Rev Gastroenterol Peru 24 : 143–157.
  10. Apt W, Aguilera X, Vega F, Miranda C, Zulantay I, Perez C, Gabor M, Apt P, 1995. Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. Am J Trop Med Hyg 52 : 532–535.
  11. Maco V, Marcos L, Terashima A, Samalvides F, Miranda E, Espinoza JR, Gotuzzo E, 2002. Fas2-ELISA y la técnica de sedimentación rápida modificada por lumbreras en el diagnóstico de la infección por Fasciola hepatica. Rev Med Hered 13 : 49–57.
  12. Espinoza JR, Timoteo O, Herrera-Velit P, 2005. Fas2-ELISA in the detection of human infection by Fasciola hepatica. J Helminthol 79 : 235–240.
  13. Kabaalioglu A, Cubuk M, Senol U, Cevikol C, Karaali K, Apaydin A, Sindel T, Lüleci E, 2000. Fascioliasis: US, CT, and MRI findings with new observations. Abdom Imaging 25 : 400–404.
  14. Lumbreras H, Cantella R, Burga R, 1962. Acerca de un procedimiento de sedimentación r ápida para investigar huevos de Fasciola hepatica en las heces, su evaluación y uso en el campo. Rev Med Peru 31 : 167–174.
  15. Hidalgo F, Valls C, Narvaez JA, Serra J, 1995. Hepatic fascioliasis: CT findings. AJR Am J Roentgenol 164 : 768.
  16. MacLean JD, Graeme-Cook FM, 2002. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-2002. A 50-year-old man with eosinophilia and fluctuating hepatic lesions. N Engl J Med 346 : 1232–1239.
  17. Han JK, Jang HJ, Choi BI, Kim SH, Kim TK, Won HJ, Kim YI, Cho SY, 1999. Experimental hepatobiliary fascioliasis in rabbits: a radiology–pathology correlation. Invest Radiol 34 : 99–108.
  18. Gonzalo-Orden M, Millan L, Alvarez M, Sánchez-Campos S, Jiménez R, González-Gallego J, Tuñón MJ, 2003. Diagnostic imaging in sheep hepatic fascioliasis: ultrasound, computer tomography and magnetic resonance findings. Parasitol Res 90 : 359–364.
  19. Teichmann D, Grobusch MP, Gobels K, Muller HP, Koehler W, Suttorp N, 2000. Acute fascioliasis with multiple liver abscesses. Scand J Infect Dis 32 : 558–560.
  20. Karabinis A, Herson S, Brucker G, Nozais JP, De Puyfontaine O, Tselentis J, Godeau P, Gentilini M, 1985. Fasciola hepatic abscesses: value of hepatic ultrasonography. Apropos of 3 cases. Ann Med Interne (Paris) 136 : 575–578.
  21. Kim JB, Kim DJ, Huh S, Cho SY, 1995. A human case of invasive fascioliasis associated with liver abscess. Korean J Parasitol 33 : 395–398.
  22. Kim KA, Lim HK, Kim SH, Lee WJ, Lim JH, 1999. Necrotic granuloma of the liver by human fascioliasis: imaging findings. Abdom Imaging 24 : 462–464.
  23. Noyer CM, Coyle CM, Werner C, Dupouy-Camet J, Tanowitz HB, Wiitner M, 2002. Hypereosinophilia and liver mass in an immigrant. Am J Trop Med Hyg 66 : 774–776.
  24. Loja D, Alvizuri J, Vilca M, Aviles R, Sanchez M, 2003. Hepatic subcapsular hematoma caused by fascioliasis. Rev Gastroenterol Peru 23 : 142–148.
  25. MacLean JD, Cross J, Mahanty S, 1999. Liver, lung, and intestinal fluke infections. Guerrant RL, Weller PF, eds. Tropical Infectious Diseases: Principles, Pathogens, & Practice. Philadelphia: Churchill Livingstone, 1039–1057.
  26. Marcos L, Maco V, Samalvides F, Terashima A, Espinoza JR, Gotuzzo E, 2006. Risk factors for Fasciola hepatica infection in children: a case–control study. Trans R Soc Trop Med Hyg 100 : 158–166.
  27. Cosme A, Ojeda E, Cilla G, Torrado J, Alzate L, Beristain X, Orive V, Arenas J, 2001. Fasciola hepatica. Study of a series of 37 patients. Gastroenterol Hepatol 24 : 375–380 (article in Spanish).
  28. Keiser J, Engels D, Buscher G, Utzinger J, 2005. Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opin Investig Drugs 14 : 1513–1526.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2008.78.222
Loading
/content/journals/10.4269/ajtmh.2008.78.222
Loading

Data & Media loading...

  • Received : 20 Jul 2007
  • Accepted : 15 Oct 2007

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error